All news
Neutral impactOrders & Deals

Gujarat Themis Biosyn Limited — Disclosure under SEBI Takeover Regulations

NSE 4d ago·14 Jul 2026, 8:47 am

PHARMACEUTICAL BUSINESS GROUP (INDIA) LIMITED has submitted to  the Exchange a copy of Disclosure under Regulation 31 of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011

Stocks in this story

Gujarat Themis Biosyn381.95 0.00%

Key takeaways

  • Concerns Gujarat Themis Biosyn (GUJTHEM).
  • Category: Orders & Deals.

Why it matters

A routine update for Gujarat Themis Biosyn. Use the price and stock snapshot to gauge how the market is responding.

Summary & analysis by DocStoX. Full story at NSE.

More Company news

More news

Latest headlines

More news

Aggregated from third-party sources for research. Sentiment & impact are AI-generated, indicative, not advice.

Gujarat Themis Biosyn Limited — Disclosure under SEBI Takeover Regulations | Gujarat Themis Biosyn (GUJTHEM)